HealthFinSMEsabout 3 hours ago
Anaheim Bio Raises 40 Million Euro
1 min read
Anaheim Bio, a Leiden-based preclinical-stage biotechnology company, raised 40 million euros in Series A funding on 05/11/2026. Backers include Droia Ventures, Frazier Life Sciences, RTW Investments, Novartis Venture Fund, RV Invest, and Thuja Capital.
Level
Hype check
Tap to vote and see what everyone thinks.